NodThera Investors

26 investors on Angel Roster list NodThera in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and France.

Investors are matched on the company name in their portfolio, so companies that share the name NodThera can appear together.

Investors listed
26
With verified email
42%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 26 NodThera investors

The most complete profiles first. Showing 26 of 26.

  • Andy SchwabVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more

    Verified email available

  • Brian DanielsVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Deborah PalestrantVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Jason RuthVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Lou TartagliaVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Verified email available

  • Rebecca ChenVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Elliot EhrichVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Jason P. HaflerVerified

    Corporate Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Verified email available

  • Jonathan WeissmanVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Laia CrespoVerified

    Venture Capital, Corporate Venture Capital, Investor · France

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Verified email available

  • Mary CanningVerified

    Venture Capital, Private Equity Firm, Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Verified email available

  • Paul StoneVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Jamil M. Beg

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • John Diekman

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Contact details available

  • Mason Freeman

    Venture Capital, Investor · United States

    SeedHealth CareHospitalsGeneticsLife Science

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Mira Chaurushiya

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsAlternative MedicineAndroid

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Scott Rocklage

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Contact details available

  • Aksana Labokha

    Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Daniel Mansuri

    Corporate Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Contact details available

  • Elizabeth Roper

    Venture Capital, Private Equity Firm, Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Joseph Victor

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Matthew Miessau

    Venture Capital, Private Equity Firm, Micro VC · United States

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Peter Finan

    Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Peter Kim

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Sinclair Dunlop

    Venture Capital, Private Equity Firm, Micro VC · United Kingdom

    Health CareGeneticsChemicalLife Science

    Portfolio: Confluence Life Sciences, Funderbeam, Edinburgh Molecular Imaging, Topas Therapeutics and 14 more

    Contact details available

  • Alex PasteurVerified

    Venture Capital, Private Equity Firm, Finance Operator · United Kingdom

    Series AHealth CareEnterprise SoftwareAndroidLife Science

    Portfolio: NodThera, Acacia Pharma

    Verified email available

Frequently asked questions

How many NodThera investors are on Angel Roster?

Angel Roster lists 26 NodThera investors. 11 of them (42%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (22), Private Equity Firms (12) and Micro VC Firms (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do NodThera investors invest in?

Among those that list a stage, the most common are Seed (11) and Series A (1).

Where are NodThera investors based?

Most are based in the United States (19), the United Kingdom (6) and France (1).

Which companies have NodThera investors backed?

The most-backed portfolio companies among them are Expansion Therapeutics (19), Escient Pharmaceuticals (19), Portal Instruments (16), Pearl Therapeutics (16) and Homology Medicines (16).

How do I contact NodThera investors?

Create a free Angel Roster account to search and filter all 26, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.